Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beyond serotonin.

H Y Meltzer1

  • 1Department of Psychiatry, Case Western Reserve University, Cleveland, Oh. 44106.

The Journal of Clinical Psychiatry
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

New depression treatments are needed due to current drug limitations. Novel therapies, potentially acting outside the serotonin system, are under investigation for improved efficacy and fewer side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.

Journal of neurochemistry·1996
Same author

Genetic variation of 5-HT2A receptor and response to clozapine.

Lancet (London, England)·1995
Same author

Association study between the dopamine D4 receptor gene and schizophrenia.

American journal of medical genetics·1995
Same author

Neuropeptide Y in frontal cortex is not altered in major depression.

Journal of neurochemistry·1995
Same author

Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men.

Biological psychiatry·1995
Same author

Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia.

Archives of general psychiatry·1995
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Current antidepressant therapies, including selective serotonin reuptake inhibitors, may not solely rely on serotonergic mechanisms.
  • Existing treatments for depression exhibit limitations in efficacy, speed of action, and side effect profiles.
  • There is a clear need for developing superior antidepressant medications and therapies.

Purpose of the Study:

  • To review novel therapeutic strategies for depression.
  • To explore treatments that may operate independently of serotonin.
  • To highlight the ongoing search for more effective depression treatments.

Main Methods:

  • Literature review of existing and emerging antidepressant therapies.
  • Analysis of potential mechanisms of action for novel treatments.

Related Experiment Videos

  • Examination of non-pharmacologic interventions for depression.

    • Main Results:

    • Novel approaches under investigation include beta-adrenergic agonists, alpha-adrenergic antagonists, tetrahydrobiopterin, GABAergic drugs, and light therapy.
    • These emerging treatments might act independently of serotonin.
    • Intriguing evidence suggests a potential link between these novel therapies and the serotonin system.

    Conclusions:

    • The limitations of current depression treatments necessitate the development of novel therapeutic strategies.
    • Emerging treatments offer potential alternatives, possibly with distinct mechanisms of action.
    • Further research is required to fully understand the mechanisms and efficacy of these novel depression therapies.